BBVA USA’s Nu Skin NUS Stock Holding History

BBVA USA’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$374K	Sell	9,246 -790	-8%	-$40K	0.02%	368
2021 Q2	$569K	Buy	+10,036	New	+$571K	0.03%	333

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BBVA USA's NUS Position: Q3 2021 in Review

BBVA USA reduced its Nu Skin (NUS) stake by 7.9% in Q3 2021, selling an estimated $40K and leaving 9,246 shares worth $374K. The position accounts for 0.02% of the portfolio, ranked #368.

BBVA USA first reported a position in NUS in Q2 2021 and has held it in 2 quarters since. The position peaked at $569K in Q2 2021. 246 funds tracked by Wall St. Rank hold NUS as of Q3 2021.

BBVA USA held 9,246 shares of Nu Skin worth $374K as of Q3 2021.
BBVA USA sold 790 Nu Skin shares in Q3 2021, an estimated $40K.
Nu Skin made up 0.02% of BBVA USA's portfolio in Q3 2021, its #368 holding.
BBVA USA first reported a position in Nu Skin in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Nu Skin position peaked at $569K in Q2 2021.
246 funds tracked by Wall St. Rank held Nu Skin as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.